Literature DB >> 35698389

Enzymatic and chemoenzymatic synthesis of human milk oligosaccharides and derivatives.

Jie Zheng1, Han Xu2, Junqiang Fang3, Xing Zhang4.   

Abstract

Human milk oligosaccharides (HMOs) are complex glycans that are the third largest solid component in human milk. It has attracted great interest in recent years due to their critical role in boosting infant health. These oligosaccharides play an important role in a variety of physiological processes, such as shaping the infant gut microbiome, preventing pathogenic infections and promoting the development of immune system. However, limited availability of HMOs hampered their use in food and medical areas. Moreover, most of the HMOs are unique to human milk and difficult to isolate. The strategies, chemical synthesis, whole-cell fermentation, and purification from human milk, have their advantages and come with their own challenges. In this review, we examined the remarkable progress that has been made in the enzymatic and chemoenzymatic synthesis of HMOs, and discussed the challenges and opportunities in large-scale synthesis of HMOs.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemoenzymatic synthesis; Enzymatic synthesis; Human milk oligosaccharides; Nutrition

Mesh:

Substances:

Year:  2022        PMID: 35698389     DOI: 10.1016/j.carbpol.2022.119564

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  2 in total

1.  Vitamins, Vegetables and Metal Elements Are Positively Associated with Breast Milk Oligosaccharide Composition among Mothers in Tianjin, China.

Authors:  Xinyang Li; Yingyi Mao; Shuang Liu; Jin Wang; Xiang Li; Yanrong Zhao; David R Hill; Shuo Wang
Journal:  Nutrients       Date:  2022-10-04       Impact factor: 6.706

Review 2.  Current Progress in the Chemoenzymatic Synthesis of Natural Products.

Authors:  Evan P Vanable; Laurel G Habgood; James D Patrone
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.